ArticleCardiovascular diabetology2025

Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands.

Sara W Quist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.